Available Guidelines: ESMO Guidelines - Revision history

Francine at 16:19, 2 December 2025

2025-12-02T16:19:01Z

← Older revision		Revision as of 16:19, 2 December 2025
Line 1:		Line 1:
			<span style="display:none">europeanunion</span>
	Go back to [[Compilation: ESMO Guidelines (European Union)]] page		Go back to [[Compilation: ESMO Guidelines (European Union)]] page

Victor at 09:53, 28 August 2024

2024-08-28T09:53:28Z

← Older revision		Revision as of 09:53, 28 August 2024
Line 30:		Line 30:
	* Gastric Cancer		* Gastric Cancer
	* Gastrointestinal cancers: Colorectal cancer (CRC) in the COVID-19 era		* Gastrointestinal cancers: Colorectal cancer (CRC) in the COVID-19 era
	* Gastrointestinal cancers: Gastro-oesophageal ~~tumors~~ in the COVID-19 era		* Gastrointestinal cancers: Gastro-oesophageal tumours in the COVID-19 era
	* Gastrointestinal cancers: Pancreatic cancer in the COVID-19 era		* Gastrointestinal cancers: Pancreatic cancer in the COVID-19 era
	* Hepatocellular Carcinoma		* Hepatocellular Carcinoma

Francine at 12:21, 30 April 2024

2024-04-30T12:21:58Z

← Older revision		Revision as of 12:21, 30 April 2024
Line 1:		Line 1:
	Go back to [[Compilation: ESMO Guidelines (European Union ~~- wide Resources~~)]] page		Go back to [[Compilation: ESMO Guidelines (European Union)]] page

	Source: [https://www.esmo.org/guidelines/guidelines-by-topic Click here to learn more].		Source: [https://www.esmo.org/guidelines/guidelines-by-topic Click here to learn more].

Francine at 19:43, 29 April 2024

2024-04-29T19:43:01Z

← Older revision		Revision as of 19:43, 29 April 2024
Line 1:		Line 1:
	Go back to [[Compilation: ESMO Guidelines (European Union - wide Resources)]] page		Go back to [[Compilation: ESMO Guidelines (European Union - wide Resources)]] page

	Source [https://www.esmo.org/guidelines/guidelines-by-topic Click here to learn more].		Source: [https://www.esmo.org/guidelines/guidelines-by-topic Click here to learn more].

	'''Breast Cancer''':		'''Breast Cancer''':

Francine at 19:42, 29 April 2024

2024-04-29T19:42:52Z

← Older revision		Revision as of 19:42, 29 April 2024
Line 1:		Line 1:
	Go back to [[Compilation: ESMO Guidelines (European Union - wide Resources)]] page		Go back to [[Compilation: ESMO Guidelines (European Union - wide Resources)]] page

	Source [https://www.esmo.org/guidelines/guidelines-by-topic].		Source [https://www.esmo.org/guidelines/guidelines-by-topic Click here to learn more].

	'''Breast Cancer''':		'''Breast Cancer''':

Francine at 17:28, 25 April 2024

2024-04-25T17:28:02Z

← Older revision		Revision as of 17:28, 25 April 2024
Line 1:		Line 1:
	Go back to [[Compilation: ESMO Guidelines (European Union - wide Resources)]] page		Go back to [[Compilation: ESMO Guidelines (European Union - wide Resources)]] page

	Source [https://www.esmo.org/guidelines/guidelines-by-topic].		Source [https://www.esmo.org/guidelines/guidelines-by-topic].

Francine at 17:27, 25 April 2024

2024-04-25T17:27:52Z

← Older revision		Revision as of 17:27, 25 April 2024
Line 1:		Line 1:
	Go back to [[~~Austria~~]] page		Go back to [[Compilation: ESMO Guidelines (European Union - wide Resources)]] page
			Source [https://www.esmo.org/guidelines/guidelines-by-topic].

	'''Breast Cancer''':		'''Breast Cancer''':

Francine at 17:53, 16 June 2023

2023-06-16T17:53:22Z

← Older revision		Revision as of 17:53, 16 June 2023
Line 1:		Line 1:
			Go back to [[Austria]] page

	'''Breast Cancer''':		'''Breast Cancer''':

Francine at 13:35, 1 June 2023

2023-06-01T13:35:15Z

← Older revision		Revision as of 13:35, 1 June 2023
Line 107:		Line 107:

	* Cutaneous Melanoma		* Cutaneous Melanoma


	'''Neuro-Oncology''':		'''Neuro-Oncology''':

Francine: Created page with "'''Breast Cancer''': * Metastatic Breast Cancer * Breast cancer in the COVID-19 era * Consensus Recommendations – Breast Cancer in Young Women (BCY5) * Early Breast Cancer * Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes '''Cancers of Unknown Primary Site''': * Cancers of Unknown Primary Site '''Endocrine and Neuroendocrine Cancers''': * Adrenocortical Carcinomas and Malignant Phaeochromocytomas * Gastroenteropancreatic Neu..."

2023-06-01T13:34:31Z

Created page with "'''Breast Cancer''': * Metastatic Breast Cancer * Breast cancer in the COVID-19 era * Consensus Recommendations – Breast Cancer in Young Women (BCY5) * Early Breast Cancer * Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes '''Cancers of Unknown Primary Site''': * Cancers of Unknown Primary Site '''Endocrine and Neuroendocrine Cancers''': * Adrenocortical Carcinomas and Malignant Phaeochromocytomas * Gastroenteropancreatic Neu..."

New page

'''Breast Cancer''':

* Metastatic Breast Cancer
* Breast cancer in the COVID-19 era
* Consensus Recommendations – Breast Cancer in Young Women (BCY5)
* Early Breast Cancer
* Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes

'''Cancers of Unknown Primary Site''':

* Cancers of Unknown Primary Site

'''Endocrine and Neuroendocrine Cancers''':
* Adrenocortical Carcinomas and Malignant Phaeochromocytomas
* Gastroenteropancreatic Neuroendocrine Neoplasms
* Lung and Thymic Carcinoids
* Thyroid cancer

'''Gastrointestinal Cancers''':

* Anal Cancer
* Biliary Tract Cancer
* Gastric Cancer
* Gastrointestinal cancers: Colorectal cancer (CRC) in the COVID-19 era
* Gastrointestinal cancers: Gastro-oesophageal tumors in the COVID-19 era
* Gastrointestinal cancers: Pancreatic cancer in the COVID-19 era
* Hepatocellular Carcinoma
* Hereditary Gastrointestinal Cancers
* Localised Colon Cancer
* Metastatic Colorectal Cancer
* Oesophageal Cancer; Pancreatic Cancer
* Rectal Cancer

'''Genitourinary Cancers''':

* Bladder Cancer
* Penile Carcinoma
* Prostate Cancer
* Renal Cell Carcinoma
* Testicular Cancer

'''Gynaecological Cancers''':
* Cervical Cancer
* Endometrial Cancer
* Gestational Trophoblastic Disease
* Gynaecological malignancies: Cervical cancer in the COVID-19 era
* Gynaecological malignancies: Endometrial cancer in the COVID-19 era
* Gynaecological malignancies: Epithelial ovarian cancer in the COVID-19 era
* Newly Diagnosed and Relapsed Epithelial Ovarian Carcinoma
* Non-Epithelial Ovarian Cancer
* Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes

'''Haematological Malignancies''':

* Acute Lymphoblastic Leukaemia
* Acute Myeloid Leukaemia
* Chronic Lymphocytic Leukaemia
* Chronic Myeloid Leukaemia
* Diffuse Large B-Cell Lymphoma
* Elderly Patient with Malignant Lymphoma
* Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
* Follicular Lymphoma
* Hairy Cell Leukaemia
* Hodgkin Lymphoma
* Management of ultra-high-risk Patients
* Mantle Cell Lymphoma
* Marginal Zone Lymphomas
* Multiple Myeloma
* Myelodysplastic Syndromes
* Peripheral T-Cell Lymphomas
* Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms
* Primary Cutaneous Lymphoma
* Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia
* Waldenstrom’s Macroglobulinaemia

'''Head and Neck Cancers''':

* Nasopharyngeal Carcinoma
* Salivary Gland Cancer
* Squamous Cell Carcinoma of the Head and Neck

'''Hereditary Syndromes''':

* Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes
* Hereditary Gastrointestinal Cancers

'''Lung and Chest Tumours''':

* Early-Stage and Locally Advanced (non-metastatic) Non-Small-Cell Lung Cancer
* Lung cancer in the COVID-19 era; Malignant Pleural Mesothelioma
* Non-Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer
* Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer
* Small-Cell Lung Cancer
* Thymic Epithelial Tumours

'''Melanoma''':

* Cutaneous Melanoma

'''Neuro-Oncology''':

* Leptomeningeal Metastasis
* High-Grade Malignant Glioma
* Neurological and Vascular Complications of Primary and Secondary Brain Tumours
* Brain Metastasis from Solid Tumours

'''Sarcoma and GIST''':

* Bone Sarcomas
* Soft Tissue and Visceral Sarcomas
* Gastrointestinal Stromal Tumours

'''Supportive and Palliative Care''':

* Palliative Care in the COVID-19 era
* Advanced Care Planning
* Anxiety and Depression
* Anaemia and Iron Deficiency in Patients With Cancer
* Bone Health in Cancer Patients
* Cancer Cachexia in Adult Patients
* Cancer Pain
* Cancer-related Fatigue
* Care at the End of Life
* Central Venous Access in Oncology
* Chemotherapy Extravasation
* Constipation in Advanced Cancer
* Delirium in Adult Cancer Patients
* Diarrhoea in Adult Cancer Patients
* Febrile Neutropaenia
* Fertility Preservation and Post-treatment Pregnancies in Post-pubertal Cancer Patients
* Infusion Reactions to Systemic Anticancer Therapy
* Management of Breathlessness in Patients with Cancer
* Management of Cardiac Disease; Management of Orphan Symptoms
* Neurotoxicity; Oral and Gastrointestinal Mucosal Injury
* Prevention and Management of Dermatological Toxicities Related to Anticancer Agents
* Prevention of Chemotherapy and Radiotherapy-Induced Nausea and Vomiting
* Prognostic Evaluation in Advanced Cancer
* Role of Patient-reported Outcome Measures
* Toxicities from immunotherapy and Venous Thromboembolism in Cancer Patients